Table 1.
Clinical and laboratory characteristics of participants.
| Variable | Total | Non-MetS (n = 241) | MetS (n = 364) | P |
|---|---|---|---|---|
| Age (year) | 53.4 ± 7.5 | 52.8 ± 7.7 | 53.8 ± 7.5 | 0.103 |
| Men, n (%) | 304(50.2) | 126(52.3) | 178(48.9) | 0.415 |
| BMI (kg/m2) | 24.3 ± 3.1 | 23.1 ± 2.4 | 25.2 ± 3.0 | < 0.001 |
| HbA1c (%) | 9.0 ± 1.1 | 9.0 ± 1.0 | 9.0 ± 1.2 | 0.521 |
| WC (cm) | 85.7 ± 6.9 | 82.6 ± 5.0 | 87.7 ± 7.2 | < 0.001 |
| TG (mmol/L) | 2.14 ± 1.38 | 1.47 ± 0.88 | 2.59 ± 1.47 | < 0.001 |
| HDL-c (mmol/L) | 1.10 ± 0.24 | 1.24 ± 0.20 | 1.01 ± 0.23 | < 0.001 |
| LDL-c (mmol/L) | 3.48 ± 0.90 | 3.47 ± 0.88 | 3.49 ± 0.90 | 0.625 |
| ApoA1 (g/L) | 1.03 ± 0.21 | 1.14 ± 0.20 | 0.96 ± 0.19 | < 0.001 |
| Monocyte (109/L) | 0.41 ± 0.10 | 0.37 ± 0.09 | 0.44 ± 0.10 | < 0.001 |
| UA (µmol/L) | 352.1 ± 85.4 | 326.1 ± 72.7 | 370.4 ± 88.9 | < 0.001 |
| Creatinine (µmol/L) | 70.5 ± 13.2 | 71.7 ± 13.5 | 69.7 ± 12.9 | 0.075 |
| ALT (IU/L) | 35.0 ± 9.0 | 34.9 ± 9.1 | 35.0 ± 9.0 | 0.874 |
| SBP (mmHg) | 132.0 ± 17.4 | 123.9 ± 13.4 | 139.1 ± 17.0 | < 0.001 |
| DBP(mmHg) | 81.2 ± 9.8 | 76.8 ± 8.1 | 84.1 ± 9.8 | < 0.001 |
| Insulin (mU/ml) | 27.6 ± 11.4 | 19.0 ± 7.7 | 33.9 ± 9.5 | < 0.001 |
| HOMA-IR | 11.5 ± 6.2 | 8.7 ± 5.4 | 12.6 ± 6.0 | < 0.001 |
| hs-CRP (mg/L) | 2.9 ± 0.9 | 2.9 ± 0.9 | 3.0 ± 1.0 | 0.788 |
| Hypertension, n (%) | 215(35.5) | 37(15.4) | 178(48.9) | < 0.001 |
| Smoking, n (%) | 218(36.0) | 81(33.6) | 137(37.6) | 0.312 |
| Drinking, n (%) | 224(37.0) | 79(32.8) | 145(39.8) | 0.079 |
| MAR (108/g) | 4.25 ± 1.69 | 3.34 ± 1.12 | 4.86 ± 1.73 | < 0.001 |
| MHR (108/mmol) | 4.02 ± 1.58 | 3.09 ± 1.16 | 4.63 ± 1.53 | < 0.001 |